Home / Publication / Early Assessment of Proarrhythmic Risk of Drugs Using the In Vitro Data and Single-cell-based In Silico Models: Proof of Concept

論文

Early Assessment of Proarrhythmic Risk of Drugs Using the In Vitro Data and Single-cell-based In Silico Models: Proof of Concept

Author(s): Mitra Abbasi, Ben Small, Nikunjkumar Patel, Masoud Jamei, Sebastian Polak

Year: 2016年11月23日

Guided by Evidence: Preparing for ICH M15 and the Next Evolution of Model-Informed Drug Development

ガイド

Early Assessment of Proarrhythmic Risk of Drugs Using the In Vitro Data and Single-cell-based In Silico Models: Proof of Concept

Early Assessment of Proarrhythmic Risk of Drugs Using the In Vitro Data and Single-cell-based In Silico Models: Proof of Concept

Guided by Evidence: Preparing for ICH M15 and the Next Evolution of Model-Informed Drug Development

Certara IQ^™ Global Roadshow

Certara IQ™ Workshop

Pediatric Drug Development: From “Wild West” to Model-Informed Confidence

メルマガ登録

クイックアクセス

ソリューション

お問合せ

Early Assessment of Proarrhythmic Risk of Drugs Using the In Vitro Data and Single-cell-based In Silico Models: Proof of Concept

Guided by Evidence: Preparing for ICH M15 and the Next Evolution of Model-Informed Drug Development

Certara IQ™ Global Roadshow

Certara IQ™ Workshop

Pediatric Drug Development: From “Wild West” to Model-Informed Confidence

メルマガ登録

クイックアクセス

ソリューション

お問合せ

Certara IQ^™ Global Roadshow